“Comparing Notes: Selected Current Issues in Drug Patent Listing and Litigation in Canada and the United States” 1 Canadian Intellectual Property Law Review 37.
Update
Comparing Notes: Selected Current Issues in Drug Patent Listing and Litigation in Canada and the United States
July 1, 2003
Republication Requests
To obtain permission to republish this publication or any other publication, contact Erica Wirthlin at wirthline@bennettjones.com.
For Informational Purposes Only
This publication provides an overview of trends and legal updates for informational purposes only. For personalized legal advice, please contact the authors.
From the Same Authors
See AllArticle
WTR: Trademark Litigation Review 2024
December 12, 2023Dominique T. Hussey & Melissa M. Dimilta
Article
Winning Strategies for Litigating Before Canadian Courts
November 24, 2023Dominique T. Hussey & Melissa M. Dimilta
Latest Insights
See All Insights See AllBlog
Data Centre West 2026: Alberta's Digital Infrastructure Moment Has Arrived
September 22, 2026Larissa D. Lees & Jessica Kennedy
Blog
From Super to Mega: Canada Proposes New "Productivity Mega Deduction" to Spur Investment
September 21, 2026Greg M. Johnson, Jared A. Mackey & Brendan Sigalet
Blog
OPC Issues New PIPEDA Guidance on Assessing Third-Party Service Providers
September 14, 2026 & 2 more
Blog
Government of Canada Reduces the Scope of the Project List under the Impact Assessment Act
September 11, 2026Ashley M. White, Martin Ignasiak KC & Nathan Murray



















